Oncologie nieuws
- Leukemia cells activate cellular recycling program
- External validation of the FAMISH predicting score for early gastric cancer with endoscopic submucosal dissection
- Preventive effects of chemical drugs on recurrence of colorectal adenomas: systematic review and Bayesian network meta-analysis
- Development and validation of the PERCEPT-PREVENT tool to determine risk perception and attitudes towards digestive cancer screening
- Efficacy and safety comparison between Lenvatinib and Sorafenib in hepatocellular carcinoma treatment: a systematic review and meta-analysis of real-world study
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- Eli Lilly’s Jaypirca approved in US for leukaemia and lymphoma treatment
- Salinomycin and IR780-loaded upconversion nanoparticles influence biological behavior of liver cancer stem cells by persistently activating the MAPK signaling pathway
- Pathogenic germline variants in non-<em>BRCA1/2</em> homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
- Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement
- Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer
- IRX2 regulates endometrial carcinoma oncogenesis by transcriptional repressing RUVBL1
- Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- AbbVie to acquire ImmunoGen for approximately $10.1bn
21-11-2023
